Shanghai Fosun Pharmaceutical (Group) Co., Ltd. announced that due to work re-arrangement, Ms. Lo Yee Har, Susan resigned as (i) a joint company secretary of the Company; and (ii) an authorized representative of the Company under Rule 3.05 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the ``Hong Kong Stock Exchange''), with effect from 17 December 2019. he Board further announces the appointment of Ms. Kam Mei Ha, Wendy (``Ms. Kam'') as a Joint Company Secretary and an Authorised Representative with effect from 17 December 2019. Ms. Kam will serve as the Joint Company Secretary to assist Ms. Dong Xiaoxian, another existing Joint Company Secretary and perform duties of Authorised Representative with Mr. Chen Qiyu.